报价延迟最少15分钟:2026/11/04 13:18 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.549 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
248.24/--
|
|
企业价值
348.24K
|
| 资产负债 |
|
每股账面净值
6.79
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
856.00K
|
|
每股收益
5.71
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products thatare all manufactured in the United States. |
